| histone methylation | GO:0016571 | 71 | 0.521 | |
| chromatin modification | GO:0016568 | 187 | 0.511 | |
| histone modification | GO:0016570 | 159 | 0.510 | |
| methylation | GO:0032259 | 134 | 0.458 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.430 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.403 | |
| macromolecule methylation | GO:0043414 | 120 | 0.384 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.332 | |
| regionalization | GO:0003002 | 337 | 0.321 | |
| protein alkylation | GO:0008213 | 81 | 0.316 | |
| histone lysine methylation | GO:0034968 | 50 | 0.313 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.310 | |
| protein methylation | GO:0006479 | 81 | 0.299 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.262 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.228 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.222 | |
| skeletal system development | GO:0001501 | 356 | 0.155 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.154 | Human |
| gene silencing | GO:0016458 | 38 | 0.149 | |
| chromatin organization | GO:0006325 | 206 | 0.143 | |
| gene silencing by rna | GO:0031047 | 19 | 0.140 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.140 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.134 | |
| gonad development | GO:0008406 | 141 | 0.133 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.133 | |
| muscle system process | GO:0003012 | 141 | 0.132 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.127 | |
| embryonic placenta development | GO:0001892 | 98 | 0.126 | |
| telencephalon development | GO:0021537 | 186 | 0.124 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.121 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.116 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.116 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.116 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.112 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.112 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.112 | |
| response to inactivity | GO:0014854 | 4 | 0.106 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.105 | |
| mrna metabolic process | GO:0016071 | 84 | 0.098 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.093 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.091 | |
| cellular response to lipid | GO:0071396 | 145 | 0.090 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.086 | |
| pharynx development | GO:0060465 | 1 | 0.085 | |
| camera type eye development | GO:0043010 | 266 | 0.081 | |
| respiratory system development | GO:0060541 | 190 | 0.081 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.081 | |
| gtp metabolic process | GO:0046039 | 144 | 0.079 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.079 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.077 | |
| compound eye development | GO:0048749 | 1 | 0.071 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.071 | |
| connective tissue development | GO:0061448 | 179 | 0.068 | |
| dendrite development | GO:0016358 | 115 | 0.068 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.067 | |
| dna metabolic process | GO:0006259 | 303 | 0.066 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.065 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.065 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.064 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.062 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.062 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.061 | |
| placenta development | GO:0001890 | 140 | 0.060 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.060 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.060 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.060 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.059 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.058 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.058 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.058 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.058 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.057 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.057 | |
| ear morphogenesis | GO:0042471 | 118 | 0.056 | |
| transdifferentiation | GO:0060290 | 1 | 0.055 | |
| fat cell differentiation | GO:0045444 | 160 | 0.055 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.054 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.054 | |
| rna processing | GO:0006396 | 105 | 0.054 | |
| wound healing | GO:0042060 | 157 | 0.054 | |
| histone acetylation | GO:0016573 | 41 | 0.053 | |
| axon guidance | GO:0007411 | 141 | 0.053 | |
| protein acylation | GO:0043543 | 64 | 0.053 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.053 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.052 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.051 | |
| gland development | GO:0048732 | 330 | 0.051 | |
| digestive system development | GO:0055123 | 200 | 0.051 | |
| circulatory system process | GO:0003013 | 197 | 0.050 | |
| segmentation | GO:0035282 | 93 | 0.049 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.049 | |
| spermatogenesis | GO:0007283 | 284 | 0.049 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.049 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.048 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.048 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.048 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.048 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.048 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.047 | |
| lung development | GO:0030324 | 164 | 0.046 | |
| cell maturation | GO:0048469 | 127 | 0.046 | |
| respiratory tube development | GO:0030323 | 167 | 0.045 | |
| neural tube development | GO:0021915 | 160 | 0.045 | |
| muscle tissue development | GO:0060537 | 308 | 0.045 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.045 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.045 | |
| neural tube formation | GO:0001841 | 108 | 0.044 | |
| stem cell differentiation | GO:0048863 | 268 | 0.044 | |
| rna interference | GO:0016246 | 2 | 0.043 | |
| amine metabolic process | GO:0009308 | 45 | 0.043 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.043 | |
| mrna processing | GO:0006397 | 63 | 0.042 | |
| regulation of histone modification | GO:0031056 | 56 | 0.042 | |
| organelle fission | GO:0048285 | 170 | 0.042 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.041 | |
| developmental maturation | GO:0021700 | 193 | 0.040 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.040 | |
| neuron death | GO:0070997 | 154 | 0.040 | |
| digestive tract development | GO:0048565 | 190 | 0.040 | |
| blastocyst formation | GO:0001825 | 33 | 0.040 | |
| rna splicing | GO:0008380 | 54 | 0.040 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.040 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.040 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.039 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.039 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.039 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.039 | |
| ossification | GO:0001503 | 216 | 0.039 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.038 | |
| cerebral cortex radial glia guided migration | GO:0021801 | 17 | 0.038 | |
| ear development | GO:0043583 | 200 | 0.038 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.038 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.038 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.038 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.038 | |
| tube formation | GO:0035148 | 140 | 0.038 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.038 | |
| brain segmentation | GO:0035284 | 3 | 0.037 | |
| hindbrain development | GO:0030902 | 128 | 0.037 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.037 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.037 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.037 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.037 | |
| somitogenesis | GO:0001756 | 69 | 0.036 | |
| male gamete generation | GO:0048232 | 285 | 0.036 | |
| cell adhesion | GO:0007155 | 329 | 0.036 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.036 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.035 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.035 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.035 | |
| germ cell development | GO:0007281 | 185 | 0.035 | |
| myotube differentiation | GO:0014902 | 105 | 0.035 | |
| primary neural tube formation | GO:0014020 | 95 | 0.035 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.035 | |
| cerebral cortex radially oriented cell migration | GO:0021799 | 31 | 0.034 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.034 | |
| tube closure | GO:0060606 | 91 | 0.034 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.034 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.034 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.034 | |
| urogenital system development | GO:0001655 | 261 | 0.033 | |
| response to steroid hormone | GO:0048545 | 56 | 0.033 | Human |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.033 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.033 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.033 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.032 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.032 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.031 | |
| regulation of system process | GO:0044057 | 200 | 0.031 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.031 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.031 | |
| skin development | GO:0043588 | 220 | 0.031 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.031 | |
| somite development | GO:0061053 | 81 | 0.030 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.029 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.029 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.029 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.029 | |
| endocrine system development | GO:0035270 | 98 | 0.029 | |
| cerebral cortex development | GO:0021987 | 86 | 0.029 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.029 | |
| neural tube closure | GO:0001843 | 90 | 0.029 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.029 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.028 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.028 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.028 | |
| blood circulation | GO:0008015 | 195 | 0.028 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.028 | |
| nuclear division | GO:0000280 | 158 | 0.028 | |
| blastocyst development | GO:0001824 | 80 | 0.028 | |
| microtubule based process | GO:0007017 | 236 | 0.028 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.028 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.028 | |
| female sex differentiation | GO:0046660 | 84 | 0.028 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.028 | |
| forebrain development | GO:0030900 | 302 | 0.028 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.028 | |
| epidermis development | GO:0008544 | 187 | 0.028 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.028 | |
| syncytium formation | GO:0006949 | 43 | 0.028 | |
| mapk cascade | GO:0000165 | 281 | 0.027 | |
| mesenchymal cell proliferation involved in ureter development | GO:0072198 | 4 | 0.027 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.027 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.027 | |
| cell fate commitment | GO:0045165 | 210 | 0.027 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.027 | |
| spinal cord development | GO:0021510 | 81 | 0.026 | |
| transmembrane transport | GO:0055085 | 412 | 0.026 | |
| protein catabolic process | GO:0030163 | 221 | 0.026 | |
| response to muscle inactivity involved in regulation of muscle adaptation | GO:0014877 | 4 | 0.026 | |
| central nervous system segmentation | GO:0035283 | 3 | 0.026 | |
| immunoglobulin production | GO:0002377 | 73 | 0.026 | |
| metencephalon development | GO:0022037 | 89 | 0.026 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.026 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.026 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.026 | |
| stem cell development | GO:0048864 | 219 | 0.026 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.025 | |
| glucose metabolic process | GO:0006006 | 92 | 0.025 | |
| chemotaxis | GO:0006935 | 247 | 0.025 | |
| genitalia development | GO:0048806 | 37 | 0.025 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.025 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.025 | |
| extracellular structure organization | GO:0043062 | 148 | 0.025 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.025 | |
| response to inorganic substance | GO:0010035 | 96 | 0.025 | |
| organ growth | GO:0035265 | 117 | 0.025 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.025 | |
| multicellular organism growth | GO:0035264 | 161 | 0.025 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.025 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.024 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.024 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.024 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.024 | |
| neuron projection guidance | GO:0097485 | 141 | 0.024 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.024 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.024 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.024 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.024 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.024 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.024 | |
| stem cell proliferation | GO:0072089 | 117 | 0.024 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.024 | |
| gtp catabolic process | GO:0006184 | 143 | 0.024 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.023 | |
| synapse organization | GO:0050808 | 125 | 0.023 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.023 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.023 | |
| ovulation cycle | GO:0042698 | 59 | 0.023 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.023 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.023 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.022 | |
| limb development | GO:0060173 | 166 | 0.022 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.022 | |
| epithelial tube formation | GO:0072175 | 130 | 0.022 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 2 | 0.022 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.022 | |
| cation transport | GO:0006812 | 399 | 0.022 | |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.022 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.022 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.022 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.022 | |
| t cell activation | GO:0042110 | 289 | 0.022 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.021 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.021 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.021 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.021 | |
| cartilage development | GO:0051216 | 140 | 0.021 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.021 | |
| regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000583 | 2 | 0.021 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.021 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.021 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.021 | |
| smad protein signal transduction | GO:0060395 | 21 | 0.021 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.020 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.020 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.020 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.020 | |
| epithelial cell development | GO:0002064 | 159 | 0.020 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.020 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.020 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.020 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.020 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.020 | |
| sensory perception | GO:0007600 | 245 | 0.020 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.020 | |
| circadian rhythm | GO:0007623 | 114 | 0.020 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.020 | |
| negative regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000584 | 2 | 0.020 | |
| regulation of cell division | GO:0051302 | 76 | 0.020 | |
| regulation of platelet derived growth factor receptor signaling pathway | GO:0010640 | 9 | 0.020 | |
| vagus nerve development | GO:0021564 | 3 | 0.019 | |
| regulation of organ growth | GO:0046620 | 61 | 0.019 | |
| sensory system development | GO:0048880 | 3 | 0.019 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.019 | |
| b cell activation | GO:0042113 | 161 | 0.019 | |
| chromatin remodeling | GO:0006338 | 32 | 0.019 | |
| mesoderm development | GO:0007498 | 100 | 0.019 | |
| male sex differentiation | GO:0046661 | 109 | 0.019 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.019 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.019 | |
| axonogenesis | GO:0007409 | 274 | 0.019 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.019 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.019 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.019 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.019 | |
| segment specification | GO:0007379 | 15 | 0.019 | |
| inflammatory response | GO:0006954 | 244 | 0.019 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.019 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.019 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.019 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.019 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.018 | |
| extraocular skeletal muscle development | GO:0002074 | 2 | 0.018 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.018 | |
| pallium development | GO:0021543 | 120 | 0.018 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.018 | |
| dna methylation | GO:0006306 | 43 | 0.018 | |
| regulation of skeletal muscle fiber differentiation | GO:1902809 | 3 | 0.018 | |
| response to growth factor | GO:0070848 | 198 | 0.018 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.018 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.018 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.018 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.018 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.018 | |
| positive regulation of growth | GO:0045927 | 104 | 0.018 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.018 | |
| adult behavior | GO:0030534 | 135 | 0.018 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.018 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.018 | |
| glandular epithelial cell maturation | GO:0002071 | 2 | 0.017 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.017 | |
| membrane organization | GO:0061024 | 245 | 0.017 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.017 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.017 | |
| female gonad development | GO:0008585 | 71 | 0.017 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.017 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.017 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.017 | |
| response to acid chemical | GO:0001101 | 111 | 0.017 | |
| fertilization | GO:0009566 | 127 | 0.017 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.017 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.017 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.017 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.017 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.017 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.017 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.017 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.017 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.017 | |
| ectoderm formation | GO:0001705 | 3 | 0.016 | |
| epithelial cell maturation involved in prostate gland development | GO:0060743 | 4 | 0.016 | |
| glucose homeostasis | GO:0042593 | 128 | 0.016 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.016 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.016 | |
| locomotory behavior | GO:0007626 | 195 | 0.016 | |
| response to muscle inactivity | GO:0014870 | 4 | 0.016 | |
| amide transport | GO:0042886 | 138 | 0.016 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.016 | |
| chromatin silencing | GO:0006342 | 15 | 0.016 | |
| innate immune response | GO:0045087 | 157 | 0.016 | |
| specification of organ position | GO:0010159 | 3 | 0.016 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.016 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.016 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.016 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.016 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.016 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.016 | |
| appendage development | GO:0048736 | 166 | 0.016 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.016 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.016 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.016 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.016 | |
| neuron migration | GO:0001764 | 122 | 0.016 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.016 | |
| cell division | GO:0051301 | 120 | 0.016 | |
| regulation of mesenchymal cell proliferation involved in lung development | GO:2000790 | 2 | 0.016 | |
| renal system development | GO:0072001 | 225 | 0.016 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.016 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.015 | |
| stem cell maintenance | GO:0019827 | 130 | 0.015 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.015 | |
| immune effector process | GO:0002252 | 321 | 0.015 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.015 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.015 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.015 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.015 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.015 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.015 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.015 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.015 | |
| sinoatrial node cell differentiation | GO:0060921 | 3 | 0.015 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.015 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.015 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.015 | |
| bone development | GO:0060348 | 120 | 0.015 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.015 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.015 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.015 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.014 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.014 | |
| neuromuscular process | GO:0050905 | 99 | 0.014 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.014 | |
| male gonad development | GO:0008584 | 88 | 0.014 | |
| muscle adaptation | GO:0043500 | 39 | 0.014 | |
| dna modification | GO:0006304 | 50 | 0.014 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.014 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.014 | |
| cardiac chamber development | GO:0003205 | 108 | 0.014 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.014 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.014 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.014 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.014 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.014 | |
| olfactory lobe development | GO:0021988 | 32 | 0.014 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.014 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.014 | |
| regulation of tongue muscle cell differentiation | GO:2001035 | 2 | 0.014 | |
| epithelial cell maturation | GO:0002070 | 15 | 0.014 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.014 | |
| lateral inhibition | GO:0046331 | 1 | 0.014 | |
| vagus nerve morphogenesis | GO:0021644 | 2 | 0.014 | |
| endomembrane system organization | GO:0010256 | 147 | 0.014 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.014 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.014 | |
| sensory perception of sound | GO:0007605 | 97 | 0.014 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.014 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.014 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.014 | |
| regulation of defense response | GO:0031347 | 233 | 0.014 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.014 | |
| carbon catabolite regulation of transcription | GO:0045990 | 4 | 0.014 | |
| cell fate determination | GO:0001709 | 32 | 0.014 | |
| positive regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901228 | 4 | 0.013 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.013 | |
| leukocyte migration | GO:0050900 | 124 | 0.013 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.013 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.013 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.013 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.013 | |
| cell cycle arrest | GO:0007050 | 37 | 0.013 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.013 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.013 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.013 | |
| visceral motor neuron differentiation | GO:0021524 | 3 | 0.013 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.013 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.013 | |
| response to denervation involved in regulation of muscle adaptation | GO:0014894 | 4 | 0.013 | |
| mammary placode formation | GO:0060596 | 4 | 0.013 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.013 | |
| negative regulation of platelet derived growth factor receptor signaling pathway | GO:0010642 | 7 | 0.013 | |
| cellular response to estrogen stimulus | GO:0071391 | 12 | 0.013 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.013 | |
| myoblast differentiation | GO:0045445 | 52 | 0.013 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.013 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.013 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.013 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.013 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.013 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.013 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.013 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 39 | 0.013 | |
| response to oxygen levels | GO:0070482 | 62 | 0.013 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.013 | |
| ovarian follicle development | GO:0001541 | 40 | 0.013 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.013 | |
| angiogenesis | GO:0001525 | 201 | 0.013 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.013 | |
| regulation of secretion | GO:0051046 | 274 | 0.013 | |
| activation of immune response | GO:0002253 | 138 | 0.013 | |
| rab protein signal transduction | GO:0032482 | 1 | 0.013 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.013 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.013 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.013 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.012 | |
| smad protein complex assembly | GO:0007183 | 1 | 0.012 | |
| endocytosis | GO:0006897 | 168 | 0.012 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.012 | |
| heart morphogenesis | GO:0003007 | 178 | 0.012 | |
| steroid metabolic process | GO:0008202 | 119 | 0.012 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.012 | |
| peptide transport | GO:0015833 | 133 | 0.012 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.012 | |
| response to starvation | GO:0042594 | 65 | 0.012 | |
| female gamete generation | GO:0007292 | 74 | 0.012 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.012 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.012 | |
| positive regulation of skeletal muscle fiber differentiation | GO:1902811 | 2 | 0.012 | |
| positive regulation of mrna metabolic process | GO:1903313 | 17 | 0.012 | |
